Executive Director, Research – Technology & Innovation for Inflammation Discovery

Executive Director, Research – Technology & Innovation for Inflammation Discovery Skip to main content#Executive Director, Research – Technology & Innovation for Inflammation Discovery page is loaded## Executive Director, Research – Technology & Innovation for Inflammation Discovery Apply remote type:
On Site locations:
US
- California
- South San Francisco time type:
Full time posted on:
Posted 8 Days Agojob requisition :
R-250811##
** Career Category
** Research## ##
** Job Description
**** Join Amgen’s Mission of Serving Patients
** At Amgen, if you feel like you’re part of something bigger, it’s because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do.

Since 1980, we’ve helped pioneer the world of biotech in our fight against the world’s toughest diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach millions of patients each year.

Amgen is advancing a broad and deep pipeline of medicines to treat cancer, heart disease, inflammatory conditions, rare diseases, and obesity-related conditions. As a member of the Amgen team, you’ll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives.

Our award-winning culture is collaborative, innovative, and science based. If you have a passion for challenges and the opportunities that lay within them, you’ll thrive as part of the Amgen team. Join us and transform the lives of patients while transforming your career.
** Executive Director, Research –*
* ** Technology & Innovation for Inflammation Discovery
**** What you will do
** Let’s do this. Let’s change the world. In this vital role as Executive Director, Research – Technology & Innovation for Inflammation Discovery, you will lead early discovery inflammation research at Amgen from target identification through preclinical assessment to IND and FIH.The Executive Director, Inflammation will provide strategic, scientific, and organizational leadership across Amgen’s Inflammation Research portfolio, with accountability for advancing high-impact programs from early discovery through clinical and regulatory support.

This role will shape and execute disease-area strategy, guide portfolio prioritization, and lead cross-functional teams to deliver innovative therapeutic approaches for diseases that are driven by immunological and inflammatory mechanisms.

The Executive Director will serve as a senior scientific leader within Inflammation Research, representing the function across governance forums, portfolio reviews, and strategic initiatives. The role requires deep expertise in immunology and inflammatory disease biology, experience leading therapeutic programs with knowledge of both large and small molecule drug discovery, and the ability to influence senior stakeholders across Research, Development, Regulatory, Translational Medicine, and Commercial organizations.

The Executive Director will develop and lead the execution of an AI-enabled discovery strategy focused on leveraging innovation in myeloid, lymphoid, epithelial and/or stromal cell biology for development of novel interventions. This leader will direct the comprehensive integration of multimodal data, including human genetics, omics data, high-throughput screening outputs and advanced computational methodologies to inform target discovery and validation, innovative purpose-built modalities, and pipeline advancement of therapeutics aimed at modulating inflammation and improving outcomes for patients with immune-mediated diseases.

This role will report into the Vice President of Inflammation and will reside in our South San Francisco office.
** Key Responsibilities
*** Lead strategic and scientific direction for a portfolio of inflammation and autoimmune disease programs, including early discovery, preclinical development, and clinical-stage support.
* Provide senior scientific leadership for immune and structural cell biology and related therapeutic strategies, including program prioritization, indication strategy, target biology, and translational…